Exudative Vitreoretinopathy 8 C6012752
Exudative Vitreoretinopathy 8 is a genetic eye disease affecting the retina and vitreous. Patients may experience progressive vision changes and are typically managed by retina specialists.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Vision loss
Retinal detachment
Generalized symptoms
(ophthalmologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Floaters
(ophthalmologic)Photopsia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-VEGF intravitreal injections
Vascular endothelial growth factor inhibitors injected directly into the eye to reduce abnormal blood vessel growth and vascular leakage characteristic of exudative vitreoretinopathy.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Laser photocoagulation
Targeted laser application to ablate abnormal retinal vessels and reduce exudation, preserving retinal structure and preventing further vision loss.
Additional treatment options
Pars plana vitrectomy
Surgical removal of vitreous gel combined with membrane peeling to address tractional complications and improve visual outcomes in advanced disease.
surgicalRegular ophthalmologic surveillance
Frequent retinal examinations with imaging to detect disease progression and determine optimal timing for intervention.
monitoringIntravitreal corticosteroid implants
Sustained-release steroid devices placed in the eye to reduce inflammation and vascular permeability in refractory cases.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Exudative Vitreoretinopathy 8 C6012752?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Exudative Vitreoretinopathy 8 C6012752. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy